Mixed chimerism
Showing 1 - 25 of 3,301
Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)
Not yet recruiting
- Kidney Failure
- +2 more
- Bone Marrow Transplant
- +2 more
- (no location specified)
Jun 9, 2023
Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow
Recruiting
- Renal Failure
- Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
- Combined bone marrow and kidney transplant
-
Boston, MassachusettsMassachusetts General Hospital
Jan 19, 2023
PD-1 Antibody, Mixed Chimerism Trial in Beijing (Toripalimab Injection)
Not yet recruiting
- PD-1 Antibody
- Mixed Chimerism
- Toripalimab Injection
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jun 27, 2021
Kidney Failure, Chronic, Renal Insufficiency Trial in Boston (drug, radiation, procedure)
Completed
- Kidney Failure, Chronic
- Renal Insufficiency
- Belatacept
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital
Oct 4, 2021
End Stage Renal Disease Trial in Boston (MEDI-507, Rituximab, Total Body Irradiation)
Completed
- End Stage Renal Disease
- MEDI-507
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 19, 2021
Kidney Transplant Rejection Trial (MDR-103)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-103
- (no location specified)
Apr 4, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Sickle Cell Disease Trial in Louisville, Durham, Pittsburgh (Enriched Hematopoetic Stem Cell Infusion)
Completed
- Sickle Cell Disease
- Enriched Hematopoetic Stem Cell Infusion
-
Louisville, Kentucky
- +2 more
Oct 6, 2020
Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)
Not yet recruiting
- Recurrent Severe Aplastic Anemia
- Refractory Severe Aplastic Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 23, 2023
Metachromatic Leukodystrophy Trial in Durham (Enriched Hematopoetic Stem Cell Infusion)
No longer available
- Metachromatic Leukodystrophy
- Enriched Hematopoetic Stem Cell Infusion
-
Durham, North CarolinaDuke University
Oct 6, 2020
Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)
Active, not recruiting
- Sickle Cell Disease
- Beta Thalassemia
- Busulfan
- +3 more
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Multiple Sclerosis Trial (hematopoetic stem cell infusion)
Active, not recruiting
- Multiple Sclerosis
- hematopoetic stem cell infusion
- (no location specified)
Jul 15, 2022
Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)
Active, not recruiting
- Renal Failure
- Enriched Hematopoietic Stem Cell Infusion
-
Chicago, Illinois
- +1 more
Jul 15, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Leukemia, Myeloid, MDS Trial in Gainesville (Lenalidomide)
Terminated
- Leukemia, Myeloid
- Myelodysplastic Syndromes
-
Gainesville, FloridaUniversity of Florida Shands Cancer Center
Jan 13, 2020
Intestinal Transplantation Trial in New York (Cell Therapy)
Recruiting
- Intestinal Transplantation
- Cell Therapy
-
New York, New YorkColumbia University Irving Medical Center/NYP
Dec 28, 2021
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell
Unknown status
- B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation
- +4 more
- Blinatumomab in combination with donor lymphocyte infusion
-
Munich, GermanyKlinikum der Universität München
Jun 13, 2019
Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)
Recruiting
- Sickle Cell Disease
- Hematopoietic stem cell transplantation
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Sickle Cell Disease Trial in Amsterdam (Engerix-B)
Recruiting
- Sickle Cell Disease
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Jan 6, 2022
Adding Azathioprine/Hydroxyurea Preconditioning to
Recruiting
- Sickle Cell Disease
- Preconditioning with azathiprine and hydroxyurea (3 months)
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Feb 9, 2022
Allogeneic Hematopoietic Cell Transplantation Trial (Alemtuzumab)
Not yet recruiting
- Allogeneic Hematopoietic Cell Transplantation
- (no location specified)
Aug 12, 2022
Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical
Recruiting
- Hemoglobinopathy (Disorder)
- +2 more
- Haploidentical Hematopoietic Cell Transplantation
-
Saint Petersburg, FloridaJohns Hopkins All Children's Hospital
Sep 13, 2022
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023